110 results
Page 3 of 6
6-K
EX-99.1
sjtov3 y4e4
30 Nov 21
Mereo BioPharma Reports Interim Data from ACTIVATE Phase 1b/2 Open Label Study of
7:51am
6-K
EX-99.2
jro86i1
2 Nov 21
Current report (foreign)
4:16pm
6-K
EX-99.1
o4kpzxvlc
1 Oct 21
Current report (foreign)
4:43pm
6-K
EX-99.1
o72 jc1vhz
2 Jun 21
Current report (foreign)
8:24am
6-K
EX-99.1
azwdhrjdgw86syy
16 Apr 21
Current report (foreign)
4:10pm
424B5
z0ktanomwt
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
0h5vmbbq9
9 Feb 21
Prospectus supplement for primary offering
5:24pm
6-K
EX-99.1
9ypx2kn
17 Dec 20
Mereo BioPharma and Ultragenyx Announce Collaboration and License
5:16pm
424B5
x98661
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
er5jivl4ydu i3i
6 Oct 20
Shelf registration (foreign)
4:25pm
6-K
EX-99.1
0lhf1by2bpb xvhb
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.2
vxl7snd qov4v
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.1
tv9n58klkoedqjy
25 Aug 20
Mereo BioPharma Announces Initiation of Placebo-Controlled Phase 1b/2 Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
11:14am
6-K
q20pm4viz7ufv xv
16 Jun 20
Current report (foreign)
4:13pm
6-K
EX-10.1
p8yprj
5 Jun 20
Mereo BioPharma Announces Completion of $70 Million Private Placement
12:00am
F-1/A
52b52mpefs1bhs 3g5
12 Mar 20
Registration statement (foreign) (amended)
5:15pm